Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies.

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
Innocens
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Innocens

Helping clinicians make faster, smarter decisions with AI-powered alerts for patient deterioration.

Universiteit Antwerpen
UZ Antwerpen
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège
AILOS
Qbic III
Deeptech
Deeptech
Deeptech
Deeptech

AILOS

AILOS is redefining actuation for next generation robotics

VUB